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A night without sleep is followed by enhanced sleepiness, increased low-frequency activ-
ity in the waking EEG, and reduced vigilant attention. The magnitude of these changes is
highly variable among healthy individuals. Findings in youngmen of low and high subjective
caffeine sensitivity suggest that adenosinergic mechanisms contribute to inter-individual
differences in sleep deprivation-induced changes in EEG theta activity, as well as optimal
performance on the psychomotor vigilance task (PVT). In comparison to young subjects,
healthy adults of older age typically feel less sleepy after sleep deprivation, and show fewer
response lapses, and faster reaction times on the PVT, especially in the morning after the
night without sleep. We hypothesized that age-related changes in adenosine signal trans-
mission underlie reduced vulnerability to sleep deprivation in older individuals. To test this
hypothesis, the combined effects of prolonged wakefulness and the adenosine receptor
antagonist, caffeine, on an antero-posterior power gradient in EEG theta activity and PVT
performance were analyzed in healthy older and caffeine-insensitive and -sensitive young
men. The results show that age-related differences in sleep loss-induced changes in brain
rhythmic activity and neurobehavioral functions aremirrored in young individuals of low and
high sensitivity to the stimulant effects of caffeine. Moreover, the effects of sleep depri-
vation and caffeine on regional theta power and vigilant attention are inversely correlated
across older and young age groups. Genetic variants of the adenosine A2A receptor gene
contribute to individual differences in neurobehavioral performance in rested and sleep
deprived state, and modulate the actions of caffeine in wakefulness and sleep. Based
upon this evidence, we propose that age-related differences in A2A receptor-mediated sig-
nal transduction could be involved in age-related changes in the vulnerability to acute sleep
deprivation.
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INTRODUCTION
Sleep deprivation affects subjective and objective measures of
alertness, attention, and vigilance, as well as higher cognitive
capabilities such as perception, memory, and executive functions
(Goel et al., 2009). There exist, however, considerable and sys-
tematic inter-individual differences in the susceptibility to the
lack of sleep. Among young healthy people, these differences are
robust, trait-like, and possibly related to genetically determined,
neurobiological differences in the physiological processes under-
lying the homeostatic and circadian regulation of wakefulness and
sleep (Landolt, 2008a; Dijk and Archer, 2010; Van Dongen et al.,
2012). Evidence from pharmacological and microdialysis studies
in animals and humans strongly suggests the involvement of the
neuromodulator adenosine and adenosine receptors in the effects
of sleep deprivation (Ticho and Radulovacki, 1991; Schwierin
et al., 1996; Porkka-Heiskanen et al., 2000; Landolt et al., 2004;
Wyatt et al., 2004;Christie et al., 2008).Adenosinergicmechanisms
may, thus, contribute to individual susceptibility or resistance to
performance impairment as a consequence of sleep loss.
To investigate this hypothesis, the combined effects of pro-
longed wakefulness and the adenosine receptor antagonist, caf-
feine, on sustained vigilant attention were studied in two groups
of young healthy men with low and high (as evidenced by expe-
riencing sleep disturbances after caffeine consumption in the
afternoon) subjective caffeine sensitivity (Rétey et al., 2006). Per-
formance on the psychomotor vigilance task (PVT), a reliable
measure of sustained vigilant attention (Lim and Dinges, 2008),
was assessed at regular intervals before, during, and after one
night without sleep. After 11 and 23 h of prolonged wakefulness,
subjects received 200mg caffeine and placebo in double-blind,
cross-over manner. This dose of caffeine equals roughly the caf-
feine content in a double-espresso. Sleep deprivation impaired
PVT performance more in caffeine-sensitive individuals than in
caffeine-insensitive individuals. This difference was counteracted
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by caffeine. These ﬁndings suggest that adenosinergic mecha-
nisms contribute to individual differences in waking-induced
impairment of neurobehavioral performance.
Normal human aging is associated with profound changes in
sleep–wake behavior. Older people may rise early without feel-
ing refreshed, feel sleepy during the day, take naps, go to bed early,
have difﬁculty falling asleep, show superﬁcial sleep with little or no
slow-wave sleep (SWS), and exhibit frequent sleep interruptions
and early morning awakenings. These alterations in the quality of
wakefulness and sleep may be secondary to health problems, or
reﬂect changes and/or disruptions in homeostatic and circadian
sleep–wake regulatorymechanisms (Dijk et al., 2010). The detailed
characteristics of sleep and sleep disorders in older age and their
possible underlying causes have been reviewed elsewhere (e.g., Bli-
wise and Carrier, 2012). Interestingly, convergent recent insights
from animal experiments as well as controlled studies in healthy
humans consistently show that older people may be less sleepy
during the daytime and better tolerate sleep deprivation when
compared to young adults (animal experiments: Wigren et al.,
2009; Hasan et al., 2012; human studies: Bonnet and Rosa, 1987;
Münch et al., 2004;Philip et al., 2004;Urrila et al., 2004;Adamet al.,
2006; Blatter et al., 2006; Duffy et al., 2009; Dijk et al., 2010). Some
authors suggested that an altered response of the adenosinergic
system contributes to these age-related changes in the behavioral
repercussions of prolonged wakefulness (Murillo-Rodriguez et al.,
2004; Rytkönen et al., 2010). This hypothesis, however, has not
been tested in humans.
In this article, we will address the question whether adenosin-
ergic mechanisms may contribute to reduced neurobehavioral
impairment from sleep deprivation in healthy older adults. First,
the current understanding of how adenosine and adenosine recep-
tors are involved in sleep–wake regulation will be recapitulated.
Then,evidencewill be summarized suggesting that the competitive
adenosine receptor antagonist, caffeine, attenuates the physiolog-
ical consequences of sleep loss on functional brain oscillations
in non-rapid-eye-movement (NREM) sleep and wakefulness, as
well as on neurobehavioral performance. Next, empirical data
will be reviewed and presented which demonstrate that older age
not only modulates functional characteristics of adenosine and
its receptors, but also the repercussions of caffeine on sleep and
waking EEG, as well as vigilant attention after sleep deprivation.
Finally, a few possible research strategies will be proposed that
could be pursued to investigate in more detail the roles for adeno-
sine and adenosine receptors in reduced vulnerability of older
adults to impaired neurobehavioral performance after the lack of
sleep.
THE NEUROMODULATOR ADENOSINE CONTRIBUTES TO THE
PHYSIOLOGICAL CONSEQUENCES OF SLEEP DEPRIVATION
The effects of the prior history of wakefulness and sleep on
functional characteristics of recovery sleep and the quality of
wakefulness have been conceptualized as sleep homeostasis in
the two-process model of sleep regulation (Borbély, 1980, 1982).
The duration of SWS and the amount of computer-detected EEG
slow-wave activity (SWA) in NREM sleep are considered the prin-
ciple markers of the sleep–wake dependent, homeostatic aspect of
sleep regulation. Biochemically, one or more endogenous “sleep
substances” may accumulate during wakefulness and dissipate
during sleep, yet the biochemical “substrates” of sleep homeosta-
sis remain poorly understood. It is widely accepted, however, that
adenosine, nitric oxide, prostaglandin D2, tumor necrosis factor,
interleukin-1, growth-hormone-releasing hormone, and brain-
derived neurotrophic factor are important chemicals that may be
primarily involved in mediating the consequences of prolonged
wakefulness. Especially with respect to adenosine, compelling and
converging evidence has accumulated over the past two decades to
support a role for this neuromodulator and its receptors in sleep
homeostasis in animals and humans (Krueger et al., 2008; Landolt,
2008b; Porkka-Heiskanen and Kalinchuk, 2011).
The formation of adenosine in the brain changes in activity-
dependent manner, and different mechanisms contribute to the
appearance of adenosine in extra-cellular space. Increased energy
demand during wakefulness leads to the break-down of energy-
rich adenine nucleosides such as adenosine-tri-phosphate (ATP).
Adenosine is formed in neurons by 5′-nucleotidase and trans-
ported through plasma and intra-cellular membranes by special-
ized transporters, including sodium-driven concentrative (CNT)
and equilibrative nucleoside transporters (ENT; Figure 1A). The
CNTs use energy tomove adenosine into the cell,whereas the ENTs
transport adenosine according to the extra-cellular/intra-cellular
concentration gradient. Elevated intra-cellular adenosine concen-
trations following increased utilization of ATP in conditions of
high energy demand lead to release of adenosine. In addition,
extra-cellular adenosine is also formed through ecto-nucleotidase-
mediated hydrolysis of ATP. Release of ATP from synaptic vesicles
occurs along with several neurotransmitters, including the major
excitatory neurotransmitter glutamate (Haydon and Carmignoto,
2006). Finally, ATP and glutamate are also released from astro-
cytes by a recently established process referred to as gliotransmis-
sion. The ATP may either be hydrolyzed to adenosine or activate
purinergic receptors such P2X7 receptors and affect sleep directly
or indirectly, yet independently from adenosine (Krueger et al.,
2008, 2010).
Molecular genetic manipulations in mice suggest that glial cells
provide a signiﬁcant source of extra-cellular adenosine in the brain
(Haydon and Carmignoto, 2006). Mice expressing a dominant-
negative (dn) SNAREdomain in astrocytes have reduced gliotrans-
mission (Pascual et al., 2005). A recent study in these mice suggests
that adenosine derived from astrocytes is importantly involved in
the homeostatic regulation of sleep pressure (Halassa et al., 2009).
Both transgenic and wild-type mice spent similar proportions of
the light-phase (i.e., themajor sleep phase inmice) inNREMsleep,
rapid-eye-movement (REM) sleep and wakefulness. By contrast,
sleep pressure (or sleep intensity) as reﬂected in SWS/SWA was
signiﬁcantly reduced when dnSNARE was expressed exclusively in
astrocytes. The differences were speciﬁc to NREM sleep and not
present in REM sleep and wakefulness, and most pronounced in
the 0.5- to 1.5-Hz range. Importantly, dnSNARE expression atten-
uated the sleep deprivation-induced increase in SWA in NREM
sleep, particularly in the low-frequency range and in hours 2–4 of
recovery sleep. Moreover, performance on a novel object recog-
nition task was unimpaired after sleep deprivation in dnSNARE
mice, while it was dramatically reduced in wild-type animals.
Taken together, these data are consistent with an important role
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FIGURE 1 | Simplified schematic representation of adenosine
formation, metabolism and transport, and G-protein coupled
adenosine receptors (rectangles representing A1, A2A, A2B, and A3
receptors). Only selected mechanisms and pathways are shown. (A)
Neurons, astrocytes, and microglia cells can release adenosine and
adenosine-tri-phosphate (ATP; gray arrow). All cell types express adenosine
receptors, adenosine transporters (cylinder), and ecto-nucleotidases that
convert ATP into adenosine. ADP, adenosine-di-phosphate; AMP,
adenosine-mono-phosphate; SAH, S-adenosyl-homocysteine; 5′-N,
5′-nucleotidase; AK, adenosine kinase; ADA, adenosine deaminase; SAHH,
S-adenosyl-homocysteine hydrolase. (B) Activation of adenosine receptors
either inhibits (A1/3 receptors) or stimulates (A2A/2B receptors) adenylate
cyclase and the cyclic AMP (cAMP) pathway.
for glia-dependent adenosine in regulating established markers of
sleep homeostasis in mice.
Clearance of extra-cellular adenosine mostly occurs through
the non-concentrative nucleoside transporters (Fredholm et al.,
2005). The main intra-cellular metabolic pathways of adenosine
are the formation of adenosine-mono-phosphate by adenosine
kinase (AK), and the irreversible break-down to inosine by adeno-
sine deaminase (ADA). Ecto-ADA also catalyzes the extra-cellular
deamination of adenosine. Mainly due to the high activity of AK,
baseline levels of extra-cellular adenosine usually remain low. The
action of ADA, which appears to be more abundantly expressed
in astrocytes than in neurons (Fredholm et al., 2005), may be par-
ticularly important when large amounts of adenosine have to be
cleared. Both, a genetic variant of ADA in humans (Bachmann
et al., 2012) and pharmacological inhibition of AK in rodents
increase SWS/SWA (Okada et al., 2003; Palchykova et al., 2010).
ADENOSINE A1 AND A2A RECEPTORS MEDIATE EFFECTS OF
ADENOSINE IN SLEEP–WAKE REGULATION
The cellular effects of adenosine are mediated via four subtypes
of G-protein coupled adenosine receptors: A1, A2A, A2B, and A3
receptors. In vitro studies indicate that physiological concentra-
tions of endogenous adenosine can activate A1, A2A, as well as
A3 receptors. Nevertheless, it is widely accepted that the high-
afﬁnity A1 and A2A receptors are primarily involved in mediating
the effects of adenosine on vigilance and sleep, at least in humans
(Sebastiao and Ribeiro, 2009).
ADENOSINE A1 RECEPTORS AND THE EFFECTS OF PROLONGED
WAKEFULNESS
The stimulation of A1 receptors opens several types of K+-
channels, inhibits adenylate cyclase through activation of Gi pro-
teins and inactivates transient voltage-dependent Ca2+-channels
(Figure 1B). The A1 receptor is ubiquitously but not homoge-
nously expressed in the central nervous system (Bauer and Ishi-
wata, 2009). In vivo imaging with the selective A1 receptor antago-
nist, 18F-CPFPX, recently developed for positron emission tomog-
raphy (PET) revealed highest receptor occupancy in striatum and
thalamus, as well as temporo-parietal and occipital cortex. Because
of the inhibition of excitatory neurotransmission after pre- and
post-synaptic A1 receptor activation and the wide-spread distrib-
ution of this receptor subtype in the brain, it has been generally
assumed that adenosine affects sleep–wake regulation primarily
via this receptor subtype. Pharmacological and genetic studies in
rats and mice, as well as molecular imaging in humans, partly
support this assumption (Schwierin et al., 1996; Thakkar et al.,
2003; Elmenhorst et al., 2007, 2009; Bjorness et al., 2009). For
example, inducible knock-out of neuronal adenosine A1 receptors
reduced SWA (3.0–4.5Hz range) in NREM sleep under baseline
conditions, and attenuated the homeostatically regulated rise in
SWAafter sleep restriction (Bjorness et al., 2009). These knock-out
mice also showed impaired working memory when sleep was cur-
tailed.Moreover, prolongedwakefulness appears to up-regulateA1
receptor binding in cortical and subcortical brain regions in ani-
mals and humans (Elmenhorst et al., 2007, 2009). Taken together,
these data indicate a role for adenosine A1 receptors in mediating
the functional consequences of sleep deprivation.
ADENOSINE A2A RECEPTORS AND THE EFFECTS OF PROLONGED
WAKEFULNESS
Stimulation of A2A receptors increases adenylate cyclase activity
through activation of Gs (or Golf in striatum) proteins, induces the
formation of inositol phosphates, and activates protein kinase A
(Figure 1B). Compared to the A1 receptor, this adenosine receptor
subtype is less widely distributed in the brain (Bauer and Ishiwata,
2009). Highest expression in the human central nervous system
was found in basal ganglia (particularly in putamen and cau-
date nucleus) and thalamus. Recent studies in rodents, including
experiments in knock-out mice, suggest that also A2A receptors
contribute to the effects of adenosine on sleep. Local adminis-
tration of the selective A2A receptor agonist, CGS21680, to the
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subarachnoid space adjacent to basal forebrain and lateral pre-
optic area increased c-fos expression in the ventro-lateral pre-optic
(VLPO) area and promoted NREM sleep (Scammell et al., 2001).
Direct activation of sleep-promoting VLPO neurons upon stimu-
lation of A2A receptors could underlie this effect (Gallopin et al.,
2005). Interestingly, preliminary data showed that mice with A2A
receptor loss-of-function may have reduced sleep and attenuated
responses to sleep deprivation (Hayaishi et al., 2004).
Taken together, both adenosine A1 and A2A receptor subtypes
probably mediate functional effects of adenosine after sleep depri-
vation, and these effects appear to be site- and receptor-dependent.
CAFFEINE ATTENUATES FUNCTIONAL CONSEQUENCES OF
SLEEP LOSS
Caffeine is the most widely consumed stimulant in the world.
In the micro-molar plasma concentrations reached after mod-
erate consumption, caffeine acts as a non-selective, competitive
antagonist at both A1 and A2A receptors. It may be important
to note, however, that caffeine fails to promote wakefulness in
mice lacking functional A2A receptors, whereas this effect is pre-
served in A1 receptor-deﬁcient mice (Huang et al., 2005). Other
effects of caffeine can also be obtained in vitro, including inhi-
bition of phosphodiesterase, blockade of GABAA receptors, and
Ca2+ release. For these actions, however, drug doses are needed
that are more than 100 times higher than those for adenosine
receptor antagonism and toxic in humans (Fredholm, 1995).
CAFFEINE ATTENUATES EEG MARKERS OF PROLONGED WAKEFULNESS
IN NREM SLEEP
Acute administration of caffeine in doses equivalent to one to
two cups of coffee (100–200mg) prolongs sleep latency, impairs
sleep efﬁciency, and reduces the duration of SWS (for review, see
Landolt, 2008b). Moreover, the stimulant induces changes in the
NREM sleep EEG, which are opposite to those of sleep depriva-
tion. Speciﬁcally, spectral power within the slow-wave range (∼1–
2.5Hz) was decreased, whereas power in the spindle frequency
range (∼12–15Hz) was increased. It is remarkable that these EEG
alterations were still observed at night, even when caffeine was
administered in the morning to either rested or sleep deprived
subjects (Landolt et al., 1995, 2004). Supporting an important
role for adenosine and adenosine receptors in the effects of sleep
deprivation, these caffeine-induced EEG changes in NREM sleep
in part mimicked the consequences of a nap in the afternoon,
which induces a physiological reduction in NREM sleep pressure
(Werth et al., 1996).
Regional EEG analyses revealed that SWA in NREM sleep is
largest over frontal cortical areas, especially after sleep deprivation
(Cajochen et al., 1999; Tinguely et al., 2006). These observations
indicate that frontal parts of the cortex reﬂect the homeosta-
tic process of sleep–wake regulation more sensitively than other
cortical regions. To study a possible contribution of adenosiner-
gic mechanisms to these regional differences, the interaction of
sleep deprivation and caffeine on the spatial distribution of low-
frequency (<1Hz) EEG power in NREM sleep was investigated
in young, self-rated caffeine-insensitive and -sensitive men (Rétey
et al., 2006). It was found that the two groups responded differently
to these challenges of sleep–wake regulation. Most interestingly,
the changes induced by caffeine were opposite to the effects of
prolonged wakefulness, and the efﬁcacy of the stimulant was
negatively correlated to the effects of sleep deprivation.
CAFFEINE ATTENUATES EEG MARKERS OF SLEEP DEPRIVATION IN
WAKEFULNESS
During prolonged wakefulness, caffeine attenuated the increase
of subjective sleepiness and EEG theta activity after sleep depri-
vation (Landolt et al., 2004). Spectral power in the theta band
(∼5–9Hz) of the waking EEG is considered an objective measure
of sleep pressure. Similar to NREM sleep, theta power increased
more in an anterior EEG derivation than in a posterior derivation,
primarily in self-rated caffeine-sensitive individuals (Rétey et al.,
2006). Moreover, caffeine attenuated the waking-induced fronto-
occipital power gradient, and the effects of sleep deprivation and
caffeine were inversely associated.
Taken together, these ﬁndings demonstrate that in those sub-
jects in whom prolonged wakefulness-induced the largest increase
in a fronto-occipital power ratio in the sleep and waking EEG, caf-
feinemost potently reduced this ratio.Moreover, caffeinemodiﬁed
the EEG in state-speciﬁc manner in those frequencies, which most
reliably reﬂect the functional consequences of sleep deprivation.
CAFFEINE IMPROVES IMPAIRED NEUROBEHAVIORAL PERFORMANCE
AFTER SLEEP DEPRIVATION
Sustained vigilant attention as reliably quantiﬁed by performance
on the PVT is also highly sensitive to wakefulness-induced impair-
ment (Lim andDinges, 2008). Optimal response speed on the PVT
was recently found to be less impaired after prolonged wakeful-
ness in self-rated caffeine-insensitive individuals than in caffeine-
sensitive subjects (Rétey et al., 2006). Also this difference was
reliably counteracted by caffeine, and the effects of sleep depriva-
tion and caffeine were inversely associated. Because the interaction
of caffeine with circadian aspects of waking performance is minor
(Wyatt et al., 2004), this study strongly suggested that adenosin-
ergic mechanisms contribute to waking-induced impairment of
neurobehavioral functions. Based on this evidence, we hypoth-
esized that increased age not only affects the susceptibility to
sleep deprivation, but also the response to the stimulant effects
of caffeine.
ADVANCED AGE ALTERS FUNCTIONAL ASPECTS OF THE
ADENOSINERGIC SYSTEM
The striking age-related reductions in SWS/SWA may reﬂect an
age-related decline in the build-up of homeostatic sleep pressure
(or sleepneed) duringwakefulness, a lower efﬁciency indissipating
sleep pressure during sleep, or an altered interplay of homeosta-
tic and circadian aspects of sleep–wake regulation. The currently
available evidence does not provide unequivocal support for an
exclusive one of these possibilities (Dijk et al., 1989, 1999, 2010;
Landolt et al., 1996; Buysse et al., 2005; Cajochen et al., 2006;
Münch et al., 2007).With respect to adenosine,microdialysis stud-
ies in rat basal forebrain revealed that extra-cellular adenosine
levels were higher in old animals (21.5months) when compared
to young animals (3.5months) in baseline and throughout sleep
deprivation (Murillo-Rodriguez et al., 2004). Given the more
superﬁcial sleep in old rats and the suggested role for adenosine
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in promoting SWS/SWA, these data indicated that the sensitivity
of adenosine receptors declines with increasing age. In support of
this hypothesis, autoradiography in rat brain slices and PET with
18F-CPFPX in humans showed that adenosineA1 receptor binding
was signiﬁcantly reduced with age in many cortical and subcorti-
cal brain regions (Meerlo et al., 2004; Meyer et al., 2007). No such
studies were performed to date to investigate age-related changes
in functional aspects of A2A receptors in the brain.
In conclusion, the available literature indicates that sleep home-
ostasis is functional in older individuals, yet impaired adeno-
sine receptor-mediated signal transduction may lead to reduced
SWS/SWA at night, lower daytime sleep propensity, and reduced
vulnerability to the neurobehavioral consequences of sleep depri-
vation.
ADVANCED AGE MODULATES THE EFFECTS OF CAFFEINE ON
THE SLEEP EEG
Drapeau et al. (2006) investigated age-related changes in the acute
effects of caffeine on sleep and the sleep EEG at night. They
found that intake of 2× 100mg caffeine within 3 h prior to bed-
time similarly lengthened sleep latency, reduced sleep efﬁciency,
and shortened sleep duration in healthy middle-aged (mean
age: 50.3± 1.6 years; n = 12) and young (23.8± 0.7 years; n = 12)
adults. Moreover, caffeine reduced∼1–4Hz activity above frontal,
central, and parietal brain areas, and increased high-frequency
power (many bins within 15–32Hz) in frontal and central EEG
derivations in both age groups. Subtle differences in the reduction
of low-delta (<1Hz) activity in the prefrontal region indicated
that the sleep EEG of the older subjects may be more sensitive
to the effects of the xanthine. In a follow-up study in 12 middle-
aged (53.8± 1.1 years) and 12 young (24.2± 1.0 years) men and
women, these authors also investigated the action of 2 × 100mg
caffeine on daytime recovery sleep after 25 h of prolonged wake-
fulness (Carrier et al., 2009). Again, caffeine similarly decreased
sleep efﬁciency, sleep duration, SWS and REM sleep, and reduced
EEG synchronization in NREM sleep (reduced 4–12Hz activity
and enhanced 14–19Hz activity) in both age groups. Neverthe-
less, the combined inﬂuence of older age and caffeine led to great
difﬁculty in the middle-aged subjects to consolidate sleep during
the daytime, at the time of a strong circadian waking signal in the
morning and early afternoon.
These experiments indicate that the sleep EEG is slightly more
vulnerable to caffeine-induced changes in middle-aged adults
when compared to young adults. This observation may challenge
the hypothesis of reduced sensitivity of adenosine receptors with
increasing age.
ADVANCED AGE ATTENUATES THE EFFICACY OF CAFFEINE
TO COUNTERACT THE CONSEQUENCES OF SLEEP
DEPRIVATION
Given the assumption that reduced vulnerability to sleep loss may
reﬂect attenuated adenosine signal transmission, it was hypoth-
esized that the effects of caffeine during prolonged wakefulness
would be reduced in older adults when compared to young adults.
To test this hypothesis, the build-up of regional EEG theta activity,
subjective sleepiness, and performance on the PVT during sleep
deprivation was examined in healthy aged and caffeine-insensitive
and -sensitive young men. It was predicted that older subjects
would respond similarly to caffeine-insensitive subjects to the
effects of both sleep deprivation and caffeine.
Inclusion criteria for all three groups were the same with
respect to habitual sleep duration (7–8 h per night), daytime
sleepiness (<10 on Epworth Sleepiness Scale), body-mass-index
(20–25 kg/m2), and habitual consumption of caffeine (one to
three caffeinated beverages per day), and alcohol (<5 drinks
per week). Physical examination conﬁrmed good health in the
older men. Before enrollment into the study, low sleep efﬁciency
(<80%), sleep apnea (apnea/hypopnea index> 5), and nocturnal
myoclonus (>5 periodic limb movements per hour of sleep) were
excluded by polysomnography in the laboratory. No study partici-
pant had a history of neurologic or psychiatric disease. All subjects
were non-smokers and denied taking any medication or consum-
ing illicit drugs. They refrained from caffeine for 2weeks prior to
the study. They were also requested to abstain from ethanol and to
maintain regular 8:16-h sleep–wake cycles for 5 days prior to the
experiment. According to the reported habitual sleep times, sleep
was scheduled from 23:00 to 07:00 (four young men, all older
men) or from 24:00 to 08:00 (18 young men). Deviation of more
than 1 h from these schedules was not allowed. Compliance with
the pre-study instructions was veriﬁed by inspecting the records
from activity monitors worn on the wrist of the non-dominant
arm, and by determining the level of caffeine in saliva and breath
ethanol concentration upon arrival in the sleep laboratory.
Because all experimental details were described in earlier pub-
lications (Adam et al., 2006; Rétey et al., 2006, 2007), they are
not fully reported here. In brief, all volunteers participated in
two blocks of four consecutive nights separated by 1week. The
ﬁrst and second nights of each block served as adaptation and
baseline nights. Then, subjects stayed awake for 40 h until bed-
time of the recovery night. Standardized waking EEG recordings,
administration of the Stanford Sleepiness Scale, and testing of
PVT performance occurred at 3-h intervals throughout prolonged
wakefulness. Two doses of 200mg caffeine and placebo in the
form of capsules were administered after 11 and 23 h of extended
wakefulness (randomized, double-blind, cross-over design). Dur-
ing sleep deprivation, the subjects remained under continuous
supervision of members of the research team. They were allowed
to read, study, play games, watch ﬁlms, and occasionally take a
walk outside the laboratory.
AGED INDIVIDUALS SHOW REDUCED EFFECTS OF SLEEP DEPRIVATION
AND CAFFEINE ON FRONTAL EEG THETA ACTIVITY
First, the effects of prolonged wakefulness on regional theta power
in the waking EEG were quantiﬁed in the placebo condition. Aver-
aged activity in the 6.25- to 8.25-Hz band recorded at 11:00,
14:00, and 17:00 after the night without sleep was expressed as
a percentage of the corresponding value in baseline (Rétey et al.,
2006). In all three groups, sleep deprivation increased theta activ-
ity in fronto-central (FC) and parieto-occipital (PO) derivations
(Figure 2). Nevertheless, the repercussions of sleep loss differed
among aged, insensitive and sensitive individuals, and between FC
and PO derivations. In particular, the increase in FC was signiﬁ-
cantly reduced in older men when compared to caffeine-sensitive
young subjects.
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FIGURE 2 | Effects of sleep deprivation and caffeine on theta power
(6.25–8.25Hz) in the waking EEG (eyes open) in fronto-central (FC,
open bars) and parieto-occipital (PO, striped bars) derivations in aged
(n =10, black bars) and caffeine-insensitive (n =10, blue bars) and
-sensitive (n =12, red bars) young men. Upper panel : to quantify the
effect of sleep deprivation, theta activity after sleep deprivation in the
placebo condition was expressed as a percentage of the corresponding
baseline value. Data represent means±SEM.Three-way mixed-model
ANOVA with the factors “group” (age, insensitive, sensitive), “deprivation”
(sleep deprivation, baseline), and “derivation” (FC, PO) revealed signiﬁcant
main effects of “deprivation” (F 1,66.1 =19.8, p<0.001) and “derivation”
(F 1,48.8 =4.8, p<0.04), as well as a signiﬁcant “group”×“derivation”
interaction (F 1,48.8 =5.2, p<0.009). *p<0.04 (two-tailed, paired t -tests),
◦p<0.04 (two-tailed, unpaired t -tests). Lower panel : to quantify the effect
of caffeine, theta activity after sleep deprivation in the caffeine condition
was expressed as a percentage of the corresponding value in the placebo
condition. Data represent means±SEM.Three-way mixed-model ANOVA
with the factors “group,” “treatment” (caffeine, placebo), and “derivation”
revealed a signiﬁcant main effect of “treatment” (F 1,36.5 =26.8, p<0.001),
as well as a signiﬁcant “group”×“derivation” interaction (F 1,28.6 =4.8,
p<0.02). *p<0.04, *p<0.07 (two-tailed, paired t -tests).
Caffeine attenuated the sleep deprivation-induced increase in
theta activity in the waking EEG (Figure 2). When all three groups
were considered, the reduction was more pronounced in the FC
derivation and only signiﬁcant in young subjects, especially in the
caffeine-insensitive group. Regression analyses revealed an inverse
relationbetween the effects of sleep deprivation and caffeine on the
FC/PO ratio in theta power (Figure 3). This ﬁnding indicates that
in those subjects in whom sleep deprivation-induced the largest
increase in the FC/PO gradient in EEG theta activity, caffeine most
potently reduced this gradient.
FIGURE 3 | Relationship between the effects of sleep deprivation and
caffeine on FC/PO power ratios in the 6.25- to 8.25-Hz band of the
waking EEG.To quantify the effect of sleep deprivation, the FC/PO ratio
after sleep deprivation in the placebo condition was expressed as a
percentage of the corresponding baseline value. To quantify the effect of
caffeine, the FC/PO ratio after sleep deprivation in the caffeine condition
was expressed as a percentage of the corresponding value in the placebo
condition. Values above 100% indicate a shift of power in anterior direction
(toward FC), whereas values below 100% indicate a shift of power in
posterior direction (toward PO). Data are plotted on a double-logarithmic
scale. Black dots: aged individuals; blue diamonds: caffeine-insensitive
individuals; red squares: caffeine-sensitive individuals. A regression line
was ﬁtted through 32 individual data points. r p: Pearson’s product-moment
correlation coefﬁcient, r s: Spearman rank correlation coefﬁcient.
AGED INDIVIDUALS SHOW REDUCED EFFECTS OF SLEEP DEPRIVATION
AND CAFFEINE ON NEUROBEHAVIORAL PERFORMANCE
Next, the evolution of subjective sleepiness and vigilant attention
in placebo and caffeine conditions were quantiﬁed at 3-h intervals
throughout sleep deprivation. Aged, as well as caffeine-insensitive
and -sensitive young subjects maintained stable performance
across the ﬁrst 16–18 h of prolongedwakefulness (Figure 4).After-
ward, sleepiness and lapses on the PVT increased, whereas slowest
and fastest reaction times on the PVT decreased. The subjective
and objective measures of vigilance in all three groups were worst
in the placebo condition in the test sessions occurring between
24 and 32 h of prolonged wakefulness. The magnitude of impair-
ment, however, differed in all variables. In general, young volun-
teers who reported high caffeine sensitivity were more impaired
by sleep deprivation than aged and caffeine-insensitive young
subjects.
Double-blind administration of caffeine improved subjective
sleepiness in aged, insensitive, and sensitive men (Figure 4). By
contrast, the stimulant attenuated the sleep loss-induced impair-
ment in vigilant attention in caffeine-sensitive subjects only. Pre-
vious analyses revealed a signiﬁcant negative correlation between
the effects of sleep deprivation and caffeine on optimal PVT per-
formance in young adults (Rétey et al., 2006). We investigated
whether this relationship is also present when the older age group
is included. To quantify the effect of caffeine on neurobehav-
ioral performance, optimal PVT speed in the caffeine condition
at 11:00, 14:00, and 17:00 after sleep deprivation was compared
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FIGURE 4 |Time course of subjective sleepiness [Stanford Sleepiness
Scale (SSS)] and performance on the psychomotor vigilance task (PVT)
across 40h waking in aged (n =10, black symbols) and
caffeine-insensitive (n =10, blue symbols) and -sensitive (n =12, red
symbols) young men.The SSS and 10-min PVT sessions were administered
every 3 h beginning 30min after awakening from the baseline night. Ticks on
the x -axes were rounded to the previous hour. Data represent means±SEM.
Caffeine (200mg) was administered 11 and 23 h into the scheduled waking
period (arrows). Open symbols: placebo condition; ﬁlled symbols: caffeine
condition. Gray shading indicates the test sessions, which showed a
signiﬁcant “group”×“treatment” interaction (seeTable 1 for further details
of the statistical analyses). *p<0.05 (false discovery rate).
to the corresponding value in the placebo condition. Indeed,
a signiﬁcant negative association between the effects of sleep
deprivation and caffeine was found (Figure 5). In other words,
including young and older individuals, those subjects with the
largest impairment from sleep loss showed the largest beneﬁt from
caffeine.
NO DIFFERENCE IN CAFFEINE PHARMACOKINETICS IN AGED,
INSENSITIVE, AND SENSITIVE INDIVIDUALS
There exist large inter-individual differences in caffeine metab-
olism in the liver that may be modiﬁed by age (Tanaka, 1998;
Rasmussen et al., 2002; Carrier et al., 2009). Therefore, it was
determined whether the different effects of caffeine on EEG and
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Table 1 | Statistical analyses of subjective sleepiness and sustained vigilant attention across 40h prolonged wakefulness.
Factors “Group”
(F ; p)
“Session”
(F ; p)
“Treatment”
(F ; p)
“Group”×
“session” (F ; p)
“Session”×
“treatment” (F ; p)
“Group”×
“treatment” (F ; p)
“Group”×“session”×
“treatment” (F ; p)
SSS 17.1; 0.000 57.9; 0.000 102.1; 0.000 2.5; 0.000 2.6; 0.002 2.2; 0.138 0.7; 0.902
PVT
Lapses 5.8; 0.009 17.0; 0.000 35.4; 0.000 2.4; 0.000 3.2; 0.002 8.4; 0.000 0.5; 0.973
Slowest 2.3; 0.136 26.2; 0.000 89.6; 0.000 2.9; 0.000 4.8; 0.002 12.3; 0.000 0.9; 0.556
Fastest 1.4; 0.267 21.1; 0.000 36.8; 0.000 1.7; 0.026 3.0; 0.001 10.4; 0.000 1.3; 0.174
To estimate the effects of sleep deprivation and caffeine, mixed-model ANOVA containing the random-effects factor “subject” and the ﬁxed-effects factors “group”
(aged, insensitive, sensitive), “session” (test sessions 1–14), and “treatment” (placebo, caffeine) were performed.The F- and p-values of the ﬁxed-effects factors are
reported; the reported p-values were controlled for the false discovery rate. Signiﬁcant p-values are highlighted by gray shading. SSS, Stanford Sleepiness Scale. PVT,
psychomotor vigilance task. Lapses=number of trials with a reaction time (RT) of longer than 500ms. Slowest= slowest 10th percentile of RTs. Fastest= fastest
10th percentile of RTs.
FIGURE 5 | Relationship between the effects of sleep deprivation and
caffeine on the 10th percentile of speed (optimal performance) on the
psychomotor vigilance task (PVT).To quantify the effect of sleep
deprivation, the 10th percentile after sleep deprivation in the placebo
condition was expressed as a percentage of the corresponding baseline
value. To quantify the effect of caffeine, the 10th percentile after sleep
deprivation in the caffeine condition was expressed as a percentage of the
corresponding value in the placebo condition. Data are plotted on a linear
scale. Black dots: aged individuals; blue diamonds: caffeine-insensitive
individuals; red squares: caffeine-sensitive individuals. A linear regression
line was ﬁtted through 32 individual data points. r p: Pearson’s
product-moment correlation coefﬁcient, r s: Spearman rank correlation
coefﬁcient.
sustained attention reﬂected different caffeine levels in saliva. One
hour after the second dose of caffeine, the concentration in saliva
equaled roughly 16–20μmol/l (aged: 19.8± 1.1μmol/l; insensi-
tive: 15.7± 2.7μmol/l; sensitive: 16.4± 2.5μmol/l). Afterward,
the drug levels declined at a similar rate in all groups and reached
almost zero at the end of sleep deprivation (Figure 6).
WHICH MECHANISMS MAY UNDERLIE REDUCED
AGE-RELATED SENSITIVITY OF THE ADENOSINERGIC
SYSTEM?
The competitive A1 and A2A receptor antagonist, caffeine,
“replaces” endogenous adenosine in dose-dependent manner
FIGURE 6 | Similar time course of saliva caffeine concentration in aged
(n =10, black dots) and caffeine-insensitive (n =9, blue diamonds) and
-sensitive subjects (n =11, red squares) young men. Samples were
collected 5min before and 30 and 60min after caffeine intake, and at 3-h
intervals following the ﬁrst dose of caffeine. The data of 1
caffeine-insensitive and 1 caffeine-sensitive individual could not be analyzed
because of insufﬁcient saliva volumes. Values represent means±SEM.
Mixed-model ANOVA with the factors “group” (aged, insensitive, sensitive)
and “time” (14 measurements) revealed no signiﬁcant difference among
the groups (“group”×“time” interaction: F 2,26 =1.2, p>0.2).
(Fredholm, 1995). Microdialysis studies in rats provided incon-
sistent results to the question whether extra-cellular adenosine
in basal forebrain is differently affected by sleep deprivation in
old and young animals (Murillo-Rodriguez et al., 2004; Rytkö-
nen et al., 2010). In humans, the half-life time of caffeine
varies widely and differences in habitual caffeine intake may
induce physiological adaptations to different cerebral caffeine
exposure. The data from carefully controlled studies demon-
strate that a ﬁxed dose of caffeine leads to similar saliva con-
centrations in aged and young individuals who have modest
habitual caffeine consumption (Figure 6; see also Carrier et al.,
2009). Thus, reduced absorption by the organism is unlikely to
underlie the attenuated effects of caffeine on waking EEG and
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neurobehavioral functions after sleep loss. Non-invasive, multi-
modal imaging techniques may be developed in the future, to
simultaneously investigate cerebral adenosine concentrations and
distinct adenosine receptor dynamics as a function of exoge-
nous ligand exposure. Such an approach could help to fur-
ther clarify the exact roles for adenosine and adenosine recep-
tors in age-related changes in individual vulnerability to sleep
deprivation.
Pharmaco-genetics provides another powerful avenue in
humans to identify molecular mechanisms underlying individual
responses to sleep loss. This strategy was successfully employed in
young adults to elucidate adenosinergic and dopaminergic mech-
anisms of sleep–wake regulation (Rétey et al., 2007; Bodenmann
and Landolt, 2010; Bodenmann et al., 2012). As a molecular basis
contributing to individual caffeine sensitivity, it was found that the
distribution of distinct c.1976T>C genotypes (single nucleotide
polymorphism rs5751876) of the adenosine A2A receptor gene
(ADORA2A) differed between self-rated caffeine-insensitive and
-sensitive people (Rétey et al., 2007). Subsequent, more sophisti-
cated genetic and laboratory studies in selected individuals showed
that common variants of ADORA2A are important determi-
nants of psychomotor vigilance in rested and sleep deprived state
(Bodenmann et al., 2012). The same gene variants also mod-
ulate the neurobehavioral response to caffeine after sleep loss.
More speciﬁcally, 2 × 200mg caffeine were ineffective to improve
sustained attention in carriers of HT4 alleles, while the same
dose efﬁciently improved performance in non-HT4 allele carri-
ers (Figure 7). These ﬁndings demonstrate that genetic variation
of ADORA2A alters the efﬁcacy of pharmacological blockade of
A2A receptors on neurobehavioral performance in young individ-
uals. Although secondary effects of caffeine cannot be excluded
(Yang et al., 2010), we suggest that age-related differences in A2A
receptor function contribute to the observed age-related changes
in neurobehavioral performance after sleep loss.
CONCLUSION
Large inter-individual differences characterize the changes
induced by prolonged wakefulness on rhythmic brain activity
and neurobehavioral performance in young and older healthy
individuals, yet the underlying neurobiological mechanisms are
not well understood. Advanced age was recently recognized to
importantly modulate individual vulnerability to sleep depriva-
tion. Consistent evidence demonstrated that the consequences of
sleep loss on sleep and waking EEG, subjective sleepiness, and
different aspect of waking state and performance are attenuated
in healthy older individuals. To receive ﬁrst insights into possi-
ble neurobiological underpinnings of these age-related changes in
humans, the combined effects of sleep deprivation and caffeine
on frontal EEG theta activity and sustained attention were eval-
uated in healthy older men. The response in this cohort to both
challenges of the sleep–wake cycle was similar to that in young
individuals who are caffeine-insensitive, and signiﬁcantly less pro-
nounced than in young caffeine-sensitive individuals. Moreover,
the effects of sleep deprivation and caffeine were inversely related.
These data provide the ﬁrst experimental evidence in humans
that impaired sensitivity of the adenosinergic system contributes
to reduced neurobehavioral consequences of sleep deprivation in
older age. Provided that genetic variation of ADORA2A in young
adults modulates subjective and objective effects of caffeine in
wakefulness and sleep, it should be investigated whether cere-
bral A2A receptors undergo functional changes in normal aging.
Future research will also have to establish whether similar age-
related changes also exist in higher cognitive processing such as
working memory and other executive functions (Van Dongen
FIGURE 7 | Genetic variation ofADORA2A modulates the effects of
caffeine on psychomotor vigilance after sleep loss.The psychomotor
vigilance task (PVT) was administered at 3-h intervals throughout prolonged
wakefulness, beginning 30min after wake-up from the baseline nights.
Mean values (±SEM) of the 10th percentile of reaction times (expressed as
speed, 1/reaction time) in young carriers of HT4 (left panels) and non-HT4
haplotype (right panels) alleles of ADORA2A are plotted. Ticks on the
x -axes were rounded to the previous hour. Compared to placebo (open
symbols), 2×200mg caffeine (ﬁlled symbols) improved optimal PVT speed
after sleep loss in non-HT4 haplotype carriers only (ANOVA: “haplotype”:
F 1,21.2 =7.91, p<0.02; “session”: F 13,205 =13.43, p<0.0001, “treatment”:
F 1,68 =8.45, p<0.005; “haplotype”×“treatment”×
“session”: F 26,219 =2.1, p<0.003). *p<0.05 (caffeine vs. placebo;
two-tailed, paired t -tests).
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et al., 2004), as well as in performance in ecological situations
such as nocturnal driving (Sagaspe et al., 2007). Given the large
demographic changes currently occurring in the Western World,
this research is of high scientiﬁc interest because it will reveal
new insights into the normal age-related changes in physiological
sleep–wake regulation. In addition, it is also of clinical importance,
because it may identify predictors and biomarkers of behavioral
and health consequences of shift work, jet lag, and voluntary sleep
restriction, which are highly prevalent in the modern “24/7” soci-
ety. Finally, it may lead to the rational development of novel,
effective,and safe countermeasures to reduce sleepiness andbehav-
ioral and cognitive impairments as a consequence of insufﬁcient
sleep.
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